Article info

Download PDFPDF

Batch-to-batch N-glycosylation study of infliximab, trastuzumab and bevacizumab, and stability study of bevacizumab
Free

Authors

  • Ana Planinc Analytical Platform of the Faculty of Pharmacy and Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Brussels, Belgium Joint Research Group ULB-VUB, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Bieke Dejaegher Joint Research Group ULB-VUB, Brussels, Belgium Laboratory of Instrumental Analysis and Bioelectrochemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Brussels, Belgium Department of Analytical Chemistry and Pharmaceutical Technology (FABI), Faculty of Medicine and Pharmacy, Center for Pharmaceutical Research (CePhaR), Vrije Universiteit Brussel (VUB), Brussels, Belgium PubMed articlesGoogle scholar articles
  • Yvan Vander Heyden Joint Research Group ULB-VUB, Brussels, Belgium Department of Analytical Chemistry and Pharmaceutical Technology (FABI), Faculty of Medicine and Pharmacy, Center for Pharmaceutical Research (CePhaR), Vrije Universiteit Brussel (VUB), Brussels, Belgium PubMed articlesGoogle scholar articles
  • Johan Viaene Joint Research Group ULB-VUB, Brussels, Belgium Department of Analytical Chemistry and Pharmaceutical Technology (FABI), Faculty of Medicine and Pharmacy, Center for Pharmaceutical Research (CePhaR), Vrije Universiteit Brussel (VUB), Brussels, Belgium PubMed articlesGoogle scholar articles
  • Serge Van Praet Pharmacy, CHU Saint-Pierre, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Florence Rappez Pharmacy, CHU Saint-Pierre, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Pierre Van Antwerpen Analytical Platform of the Faculty of Pharmacy and Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Brussels, Belgium Joint Research Group ULB-VUB, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Cédric Delporte Analytical Platform of the Faculty of Pharmacy and Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Brussels, Belgium Joint Research Group ULB-VUB, Brussels, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Ana Planinc, Faculty of Pharmacy, Laboratory of Pharmaceutical Chemistry and Analytical Platform of the Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Bld du Triomphe, Campus Plaine, CP 205/05B, Brussels B-1050, Belgium; aplaninc{at}ulb.ac.be
View Full Text

Citation

Planinc A, Dejaegher B, Vander Heyden Y, et al
Batch-to-batch N-glycosylation study of infliximab, trastuzumab and bevacizumab, and stability study of bevacizumab

Publication history

  • Received June 15, 2016
  • Revised August 24, 2016
  • Accepted August 30, 2016
  • First published September 15, 2016.
Online issue publication 
August 29, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.